| Citation: |
LI Tianyu, ZHAO Bangbo, LI Zeru, ZHAO Yutong, HAN Xianlin, ZHANG Taiping, DAI Menghua, GUO Junchao, WANG Weibin. Surgical Efficacy and Quality of Life of Total Pancreatectomy versus Pancreatico- duodenectomy for Pancreatic Cancer: A Retrospective Cohort Study Based on Propensity Score Matching[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 807-818. DOI: 10.12290/xhyxzz.2024-0163
|
To investigate the differences in postoperative short-term complications and long-term prognosis of pancreatic cancer(PC) patients after total pancreatectomy(TP) and pancreaticoduodenectomy(PD).
Clinical data of PC patients who underwent TP from January 2016 to December 2021(TP group) and PD from January 2019 to December 2021(PD group) at Peking Union Medical College Hospital were retrospectively collected. Patients in the PD group were divided into the pancreatic fistula(PF) high-risk PD group and the recurrence high-risk PD group according to risk factors. After propensity score matching, the differences in postoperative short-term surgical efficacy indicators(postoperative complication rate, 30 d mortality rate, length of hospital stay, etc.), long-term surgical efficacy indicators(overall survival), and quality of life were compared between the TP group and the PF high-risk PD group or the recurrence high-risk PD group.
A total of 32 patients in the TP group and 114 patients in the PD group(99 patients in the PF high-risk PD group and 15 patients in the recurrence high-risk PD group) meeting the inclusion and exclusion criteria were enrolled.(1)TP group and PF high-risk PD group: after propensity score matching, 29 patients in the TP group and 56 patients in the PF high-risk PD group were finally included. There was no PF in the TP group, and the rate of PF in the PF high-risk PD group was 19.64%(P=0.027).There were no statistical differences in short-term surgical efficacy indicators such as other postoperative complication rates, Clavien-Dindo grading, length of stay, ICU stay, and 30 d mortality between the two groups(all P > 0.05). At the median follow-up time of 36 months, there was no significant difference in the quality of life questionnaire-core 30(QLQ-C30) scores between the two groups(P > 0.05).(2)TP group and recurrent high-risk PD group: Since there were no statistically significant differences between the baseline data of the two groups(P > 0.05), 32 patients in the TP group and 15 patients in the recurrent high-risk PD group were both included in the analysis. There was no PF in the TP group, and the rate of PF in the recurrent high-risk PD group was 20.00%(P=0.028).The other postoperative complication rates, Clavien- Dindo grading, length of hospital stay, ICU stay, 30 d mortality and other short-term surgical efficacy indicators were also not statistically different between the two groups(all P > 0.05). By the final follow-up, the median overall survival was longer in the TP group than the recurrent high-risk PD group(37.68 months vs. 15.24 months, HR=2.551, 95% CI: 1.144-5.689, P=0.018). Multifactorial Cox regression showed that recurrent high-risk PD and preoperative obstructive jaundice were independent risk factors in the poor long-term prognosis of patients with PC.
For PC patients at high risk of PF, TP can achieve short-term surgical outcomes and long-term quality of life comparable to PD with no burden of postoperative pancreatic fistula. For patients with high-risk recurrence, TP can significantly prolong the survival of PC patients while ensuring surgical safety.
| [1] |
Schneider M, Hackert T, Strobel O, et al. Technical advances in surgery for pancreatic cancer[J]. Br J Surg, 2021, 108(7): 777-785. DOI: 10.1093/bjs/znab133
|
| [2] |
Li T Y, Qin C, Zhao B B, et al. Risk stratification of clinically relevant delayed gastric emptying after pancreaticoduodenectomy[J]. BMC Surg, 2023, 23(1): 222. DOI: 10.1186/s12893-023-02110-7
|
| [3] |
Schuh F, Mihaljevic A L, Probst P, et al. A simple classification of pancreatic duct size and texture predicts postoperative pancreatic fistula: a classification of the international study group of pancreatic surgery[J]. Ann Surg, 2023, 277(3): e597-e608. DOI: 10.1097/SLA.0000000000004855
|
| [4] |
Marchegiani G, Perri G, Burelli A, et al. High-risk pancreatic anastomosis versus total pancreatectomy after pancreatoduodenectomy: postoperative outcomes and quality of life analysis[J]. Ann Surg, 2022, 276(6): e905-e913. DOI: 10.1097/SLA.0000000000004840
|
| [5] |
Sommier L, Panaro F. Decision-making in high-risk leakage duodenopancreatectomy: pancreatic anastomosis or total pancreatectomy?[J]. Hepatobiliary Surg Nutr, 2023, 12(4): 567-569. DOI: 10.21037/hbsn-23-193
|
| [6] |
Stoop T F, Bergquist E, Theijse R T, et al. Systematic review and meta-analysis of the role of total pancreatectomy as an alternative to pancreatoduodenectomy in patients at high risk for postoperative pancreatic fistula: is it a justifiable indication?[J]. Ann Surg, 2023, 278(4): e702-e711. DOI: 10.1097/SLA.0000000000005895
|
| [7] |
林荣贵, 黄鹤光, 陈燕昌, 等. 胰颈切缘阳性的胰头腺癌行全胰十二指肠切除术的临床疗效[J]. 中华消化外科杂志, 2014, 13(11): 864-866.
Lin R G, Huang H G, Chen Y C, et al. Clinical efficacy of total pancreaticoduodenectomy for the pancreatic head adenocarcinoma with positive neck margin[J]. Chin J Dig Surg, 2014, 13(11): 864-866.
|
| [8] |
Hernandez J, Mullinax J, Clark W, et al. Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins[J]. Ann Surg, 2009, 250(1): 76-80. DOI: 10.1097/SLA.0b013e3181ad655e
|
| [9] |
Stoop T F, Ghorbani P, Scholten L, et al. Total pancreatectomy as an alternative to high-risk pancreatojejunostomy after pancreatoduodenectomy: a propensity score analysis on surgical outcome and quality of life[J]. HPB(Oxford), 2022, 24(8): 1261-1270.
|
| [10] |
中华医学会外科学分会胰腺外科学组, 中国研究型医院学会胰腺疾病专业委员会, 中华外科杂志编辑部. 胰腺术后外科常见并发症防治指南(2022)[J]. 中华外科杂志, 2023, 61(7): e1-e18.
Study Group of Pancreatic Surgery in China Society of Surgery of Chinese Medical Association, Pancreatic Disease Committee of China Research Hospital Association, Editorial Board of Chinese Journal of Surgery. The guideline for prevention and treatment of common complications after pancreatic surgery(2022)[J]. Chin J Surg, 2023, 61(7): e1-es18.
|
| [11] |
Nolte S, Liegl G, Petersen M A, et al. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15, 386 persons across 13 European countries, Canada and the Unites States[J]. Eur J Cancer, 2019, 107: 153-163. DOI: 10.1016/j.ejca.2018.11.024
|
| [12] |
Scholten L, Latenstein A E J, van Eijck C, et al. Outcome and long-term quality of life after total pancreatectomy(PANORAMA): a nationwide cohort study[J]. Surgery, 2019, 166(6): 1017-1026. DOI: 10.1016/j.surg.2019.07.025
|
| [13] |
Casadei R, Ricci C, Taffurelli G, et al. Is total pancreatectomy as feasible, safe, efficacious, and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study[J]. J Gastrointest Surg, 2016, 20(9): 1595-1607. DOI: 10.1007/s11605-016-3201-4
|
| [14] |
Zhu J S, Jiang Z Y, Xie B, et al. Comparison of oncologic outcomes between pancreaticoduodenectomy and total pancreatectomy for pancreatic adenocarcinoma[J]. Surg Endosc, 2023, 37(1): 109-119. DOI: 10.1007/s00464-022-09441-1
|
| [15] |
Balzano G, Zerbi A, Aleotti F, et al. Total pancreatectomy with islet autotransplantation as an alternative to high-risk pancreatojejunostomy after pancreaticoduodenectomy: a prospective randomized trial[J]. Ann Surg, 2023, 277(6): 894-903. DOI: 10.1097/SLA.0000000000005713
|
| [16] |
Callery M P, Pratt W B, Kent T S, et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy[J]. J Am Coll Surg, 2013, 216(1): 1-14. DOI: 10.1016/j.jamcollsurg.2012.09.002
|
| [17] |
Mungroop T H, Van Rijssen L B, Van Klaveren D, et al. Alternative fistula risk score for pancreatoduodenectomy(a-FRS): design and international external validation[J]. Ann Surg, 2019, 269(5): 937-943. DOI: 10.1097/SLA.0000000000002620
|
| [18] |
Crippa S, Tamburrino D, Partelli S, et al. Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes[J]. Surgery, 2011, 149(1): 79-86. DOI: 10.1016/j.surg.2010.04.007
|
| [19] |
Crippa S, Belfiori G, Tamburrino D, et al. Indications to total pancreatectomy for positive neck margin after partial pancreatectomy: a review of a slippery ground[J]. Updates Surg, 2021, 73(4): 1219-1229. DOI: 10.1007/s13304-021-01141-0
|
| [20] |
Schmidt C M, Glant J, Winter J M, et al. Total pancreatectomy(R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma[J]. Surgery, 2007, 142(4): 572-578. DOI: 10.1016/j.surg.2007.07.016
|
| [21] |
Sugiura T, Uesaka K, Mihara K, et al. Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer[J]. Surgery, 2013, 154(5): 1078-1086. DOI: 10.1016/j.surg.2013.04.015
|
| [22] |
López J C, Ielpo B, Iglesias M, et al. The impact of vascular margin invasion on local recurrence after pancreatoduodenectomy in pancreatic adenocarcinoma[J]. Langenbecks Arch Surg, 2024, 409(1): 122. DOI: 10.1007/s00423-024-03301-3
|
| [23] |
Ghaneh P, Kleeff J, Halloran C M, et al. The impact of positive resection margins on survival and recurrence following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma[J]. Ann Surg, 2019, 269(3): 520-529. DOI: 10.1097/SLA.0000000000002557
|
| [24] |
Joliat G R, Allemann P, Labgaa I, et al. Prognostic value of positive histological margins in patients with pancreatic head ductal adenocarcinoma and lymph node involvement: an international multicentric study[J]. HPB(Oxford), 2021, 23(3): 379-386.
|
| [25] |
Andrén-Sandberg Å, Ansorge C, Yadav T D. Are there indications for total pancreatectomy in 2016?[J]. Dig Surg, 2016, 33(4): 329-334. DOI: 10.1159/000445018
|
| [26] |
Stoop T F, Ateeb Z, Ghorbani P, et al. Impact of endocrine and exocrine insufficiency on quality of life after total pancreatectomy[J]. Ann Surg Oncol, 2020, 27(2): 587-596. DOI: 10.1245/s10434-019-07853-3
|
| [27] |
Zhao T Y, Fu Y, Zhang T P, et al. Diabetes management in patients undergoing total pancreatectomy: a single center cohort study[J]. Front Endocrinol(Lausanne), 2023, 14: 1097139.
|
| [28] |
Shaw K, Thomas A S, Rosario V, et al. Long term quality of life amongst pancreatectomy patients with diabetes mellitus[J]. Pancreatology, 2021, 21(3): 501-508.
|
| 1. |
唐雯洁. 人工智能助手“小胰宝”在老年胰腺癌患者中的应用研究进展. 老年医学与保健. 2025(01): 267-269 .
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: